Supply Chain
The deal with Pfizer will reduce the price of the company’s prescription drugs for Medicaid to Most Favored Nation pricing.
The president says he will impose the tariffs on non-generic drugs unless manufacturers build plants in America.
Hospitals should start with data when going to payers to request a carve-out in contracts due to tariffs, says Ralph Keiser, CEO of ArcheHealth.
Amneal Pharmaceuticals’ laboratory procedures resulted in visibly contaminated injectable medications, FDA says.
"Providers don't want to see rebate models, period," says Attorney Jeff Davis.
The company says broad tariffs would raise costs, limit patient access and undermine domestic manufacturing.
The agency is recommending that hospitals, health systems and clinics use the FDA-approved drug when available.
Tariffs and drug pricing reforms are a top priority, overtaking traditional concerns such as workforce challenges and cybersecurity.
Dr. Sophia Toya prescribed thousands of orthotic braces that were not medically necessary, DOJ says.
Almost three-quarters of respondents say they're concerned specifically about revenue growth and operating profitability.